rEVO Biologics (United States)

Long-term Outcome for Large Meniscal Defects Treated with Small Intestinal Submucosa in a Dog Model

James L. Cook, D. B. Fox, Prasanna Malaviya et al. · The American Journal of Sports Medicine · 2005 · 107 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Genetic, Structural, and Functional Evidence Link <i>TMEM175</i> to Synucleinopathies

Lynne Krohn, Tuǧba N. Öztürk, Benoît Vanderperre et al. · Annals of Neurology · 2019 · 107 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Evaluation of autologous chondrocyte transplantation via a collagen membrane in equine articular defects – results at 12 and 18 months

David D. Frisbie, Stephen M. Bowman, H.A. Colhoun et al. · Osteoarthritis and Cartilage · 2007 · 75 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Nonclinical Evaluation of GMA161—An Antihuman CD16 (FcγRIII) Monoclonal Antibody for Treatment of Autoimmune Disorders in CD16 Transgenic Mice

Meghan Flaherty, Timothy K. MacLachlan, Misty Troutt et al. · Toxicological Sciences · 2011 · 34 citations

Life Sciences, Immunology, Pathology +10

Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia

Michael J. Paidas, Allan T.N. Tita, George A. Macones et al. · American Journal of Obstetrics and Gynecology · 2020 · 28 citations · Full text

Medicine, Maternal Health, Obstetrics +16